openPR Logo
Press release

Future Business Opportunities in Drug and Gene Delivery Devices Industry 2024-2031: Forecast with Growth Analysis By Key Players | Bluebird bio, Inc., Becton Dickinson and Company, Amgen, Inc

07-09-2024 11:41 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Drug and Gene Delivery Devices Market

Drug and Gene Delivery Devices Market

The Drug and Gene Delivery Devices Market was valued at US$ 152.2 Thousand in 2022 and is forecast to reach a value of US$ 364.9 Thousand by 2030 at a CAGR of 11.6% between 2023 and 2030.

The latest research study released by Coherent Market Insights on the "Drug and Gene Delivery Devices Market 2024" offers an extensive and accurate analysis of both global and regional markets. The analysts and researchers behind the report have conducted a thorough competitive analysis of the market, including comprehensive profiles of leading market players. This study relies heavily on both primary and secondary data sources, examining various factors that influence the Drug and Gene Delivery Devices market environment, competitive landscape, historical data, current trends, technological innovations, upcoming technologies, and advancements in related industries.

Additionally, the Drug and Gene Delivery Devices Market analysis provides detailed market statistics, drivers, and restraints, along with their impact on demand during the forecast period of 2024-2031. The study identifies key market indicators that affect market growth and highlights the current scenario, upcoming trends, and developments that contribute to the growth of the Market. The report clearly outlines the competitive landscape, aiding in better decision-making. Overall, the report serves as a valuable tool for market players to enhance their competitiveness.

Request a Sample Copy with More Details: - https://www.coherentmarketinsights.com/insight/request-sample/5864

Scope of Drug and Gene Delivery Devices Market:

Emerging trends, The report on the market gives the complete picture of demands and opportunities for the future that are beneficial for individuals and stakeholders in the market. This report determines the market value and the growth rate based on the key market dynamics as well as the growth-improving factors. The entire study is based on the latest industry news, market trends, and growth probability. It also consists of a deep analysis of the market and competing scenario along with a SWOT analysis of the well-known competitors.

The Leading Players involved in the global Drug and Gene Delivery Devices market are:

◘ Pfizer Inc.
◘ Novartis AG
◘ Kite Pharma Inc.
◘ Bluebird bio Inc.
◘ Becton Dickinson and Company
◘ Amgen Inc.
◘ Vericel Corporation
◘ uniQure N.V.
◘ Spark Therapeutics Inc.
◘ Renova Therapeutics
◘ Orchard Therapeutics plc
◘ Kolon Tissue Gene Inc.
◘ Human Stem Cell Institute
◘ Dendreon Pharmaceuticals
◘ Helixmith Co.
◘ Ltd (ViroMed Co.
◘ Ltd), Bausch & Lomb Incorporated
◘ Castle Creek Biosciences
◘ Inc (Fibrocell Technologies Inc.)
◘ among others

Market Segments:

According to the report, the Market is segmented in the following ways which fulfill the market data needs of multiple stakeholders across the industry value chain -

By Product :Sub-retinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe, Pre-filled Syringe, and Infusion Bags
By Commercialized Drugs: Luxturna (Drug Delivery Devices), Yescarta (Drug Delivery Devices), Zolgensma (Drug Delivery Devices), Kymriah (Drug Delivery Devices), Provenge (Drug Delivery Devices), and Strimvelis (Drug Delivery Devices)

Competitive Analysis: Drug and Gene Delivery Devices Market:

To offer a more detailed understanding of the Drug and Gene Delivery Devices Market, the study segments based on geography, product, and application. This segmentation helps to identify key market trends, opportunities and challenges specific to each region, product, and application. In a recent report on the Drug and Gene Delivery Devices market, the industry's key players have been thoroughly analyzed. The report researched into multiple aspects, such as collaborations, mergers, innovative business policies, and strategies, offering insightful perspectives into significant trends and breakthroughs in the market.

Market Regional Analysis:

Geographically, The Detailed analysis of Consumption, Revenue, Market Share, and Growth Rate of the Following Regions:

› North America: USA, Canada, Mexico, etc.
› Asia-Pacific: China, Japan, Korea, India, and Southeast Asia
› The Middle East and Africa: Saudi Arabia, the UAE, Egypt, Turkey, Nigeria, and South Africa
› Europe: Germany, France, the UK, Russia, and Italy
› South America: Brazil, Argentina, Columbia, etc.

The report helps in providing a wider introduction to the market and also helps in dealing with the detailed methodology of research for the calculation of the size and forecasts of the market. The sources of secondary data are used and the primary inputs are taken for the validation of data. This section also helps in the outlines the several segments that have also been covered as a part of the report. Additionally, the Research Methodology reviews tend of providing the calculation for determining the inclinations of the global market.

Purchase this Complete Market Report and Get (Up to 25% OFF) at: https://www.coherentmarketinsights.com/insight/buy-now/5864

Key Benefits for Stakeholders:

The study provides a quantitative analysis of current Drug and Gene Delivery Devices Market trends, estimates, and market dynamics from 2024 to 2031, highlighting the most promising opportunities.
Porter's five forces analysis underscores the significance of buyers and suppliers, helping stakeholders make profitable business decisions and expand their supplier-buyer networks.
In-depth analysis, including market size and segmentation, assists in identifying current opportunities within the Drug and Gene Delivery Devices Market.
The report maps the largest countries in each region based on their revenue contributions to the market.
The Drug and Gene Delivery Devices Market research report offers a comprehensive analysis of the current status of the major players in the Drug and Gene Delivery Devices Market.

Reasons To Buy:

➦ The research would help top administration/policymakers/professionals/product advancements/sales managers and stakeholders in this market in the following ways.
➦ The report provides Drug and Gene Delivery Devices Market revenues at the worldwide, regional, and country levels with a complete analysis to 2031 permitting companies to analyze their market share and analyze projections, and find new markets to aim for.
➦ To understand the most affecting driving and restraining forces in the market and their impact on the global market.
➦ Major changes and assessment in market dynamics and developments.
➦ The objective of the Drug and Gene Delivery Devices Market report is to identify new business opportunities using quantitative market forecasts.
➦ Formulate sales and marketing strategies by gaining an understanding of competitors, their positioning, and strengths & weaknesses

FAQ's:

➤ What is the size of the market in terms of revenue, sales volume, or the number of users/customers?
➤ Who are the key players in the market, and what are their market shares?
➤ What are the trends and drivers shaping the market, and what are the challenges and opportunities?
➤ What are the different segments of the market, and how are they expected to grow?
➤ What are the key products or services offered in the market, and how do they compare to each other?
➤ What are the pricing strategies and competitive landscape of the market?
➤ What are the regulatory and legal factors affecting the market?
➤ What are the marketing and promotional strategies used by companies in the market?
➤ What are the customer preferences and buying behaviors in the market?
➤ What are the future prospects and growth potential of the market?

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5864

Why Choose This Drug and Gene Delivery Devices Market Report:

- Gain a reliable outlook of the global Drug and Gene Delivery Devices market forecasts from 2024 to 2031 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.

About Author:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.
(LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
Australia:+61-2-4786-0457
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Future Business Opportunities in Drug and Gene Delivery Devices Industry 2024-2031: Forecast with Growth Analysis By Key Players | Bluebird bio, Inc., Becton Dickinson and Company, Amgen, Inc here

News-ID: 3572110 • Views:

More Releases from Coherent Market Insights

Electronic Skin Market Size, Share, Trends, Opportunities, Key Drivers and Growth Prospectus, Segmentation Overview By 2031 | Abbott, Medtronic, MC10, Tapecon, Inc.,
Electronic Skin Market Size, Share, Trends, Opportunities, Key Drivers and Growt …
Coherent Market Insights Published the Latest Electronic Skin Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends and forecast period 2024-2031. The Electronic Skin business report's clear, reliable, and thorough market data and information will undoubtedly aid in business development and boost return on investment (ROI). The region that is predicted to generate the greatest potential in the global Electronic Skin market is
Strategic Forecast of the Cycle Tourism Market: USD US$ 241.27 billion Value and CAGR of 9.5% Analysis for 2024-2031 | Butterfield & Robinson, Backroads, Trek Travel
Strategic Forecast of the Cycle Tourism Market: USD US$ 241.27 billion Value and …
The global cycle tourism market size was valued at US$ 127.82 billion in 2024 and is expected to reach US$ 241.27 billion by 2031, growing at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2031. The Cycle Tourism Market involves travel and leisure activities centered around cycling, where tourists use bicycles to explore destinations, participate in cycling events, and experience local cultures. This segment includes various types of
Recycled Metal Market Forecast Report: US$ 96.44 Bn Revenue and CAGR of 8.5% Estimates for 2024 to 2031 | Sims Metal Management Ltd., Schnitzer Steel Industries
Recycled Metal Market Forecast Report: US$ 96.44 Bn Revenue and CAGR of 8.5% Est …
Global recycled metal market is expected to be valued at US$ 54.48 Bn in 2024, and is projected to reach US$ 96.44 Bn by 2031, exhibiting a CAGR of 8.5% from 2024 to 2031. The Recycled Metal Market involves the collection, processing, and resale of metal that has been recovered from various sources, including industrial waste, consumer products, and end-of-life equipment. These recycled metals, which include aluminum, copper, steel, and others,
Investment Opportunities in Alloy Strips : US$ 41.60 Bn Revenue Forecast and CAGR of 5.8% Trends (2024-2031) | Nippon Steel Corporation, Thyssenkrupp AG
Investment Opportunities in Alloy Strips : US$ 41.60 Bn Revenue Forecast and CAG …
The Global Alloy Strips Market size was valued at US$ 28.04 Bn in 2024 and is expected to reach US$ 41.60 Bn by 2031, grow at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031. The Alloy Strips Market encompasses the production and utilization of thin metal strips made from various alloys, including aluminum, steel, and copper, used in a wide range of industrial and consumer applications. These

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug